22 Stocks Moving In Wednesday's Pre-Market Session

Gainers

  • Derma Sciences Inc (NASDAQ: DSCI) shares rose 40 percent to $7.00 in pre-market trading after the company agreed to be acquired by Integra Lifesciences Holdings Corp (NASDAQ: IART) for $7.00 per share in cash.
  • Biocept Inc (NASDAQ: BIOC) shares rose 31.5 percent to $2.38 in pre-market trading after surging 77.45 percent on Tuesday.
  • Enphase Energy Inc (NASDAQ: ENPH) rose 22.1 percent to $1.38 in pre-market trading after the company reported a $10 million strategic investment from T.J.Rodgers and John Doerr.
  • TG Therapeutics Inc (NASDAQ: TGTX) shares rose 18 percent to $5.90 in pre-market trading after the company disclosed positive MS study data.
  • Geron Corporation (NASDAQ: GERN) rose 13.6 percent to $2.50 in pre-market trading after declining 0.45 percent on Tuesday.
  • Achaogen Inc (NASDAQ: AKAO) shares rose 9.3 percent to $16.90 in pre-market trading after Baker Bros Advisors reported a 13.1 percent stake in the company.
  • WaferGen Bio-systems, Inc. (NASDAQ: WGBS) rose 7.6 percent to $5.96 in pre-market trading after gaining 9.27 percent on Tuesday.
  • Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) shares rose 6 percent to $2.14 in pre-market trading after climbing 6.88 percent on Tuesday.
  • Neuralstem, Inc. (NYSE: CUR) rose 5.5 percent to $6.39 in pre-market trading after climbing 59.06 percent on Tuesday.
  • Keryx Biopharmaceuticals (NASDAQ: KERX) rose 4.8 percent to $6.50 in pre-market trading. Citigroup upgraded Keryx Biopharmaceuticals from Sell to Neutral.
  • Merck & Co., Inc. (NYSE: MRK) rose 3.5 percent to $62.00 in pre-market trading after the company disclosed that it has received the FDA acceptance of supplemental Biologics License Application for KEYTRUDA.
  • Sangamo Therapeutics Inc (NASDAQ: SGMO) shares rose 2.8 percent to $3.75 in pre-market trading after the company disclosed that it has received Orphan Drug designation from the FDA for SB-318.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Novadaq Technologies Inc. (NASDAQ: NVDQ) fell 17.1 percent to $6.34 in pre-market trading after the company issued a weak sales forecast.
  • Signal Genetics Inc (NASDAQ: SGNL) shares fell 12.8 percent to $15.25 in the pre-market trading session after surging 264.93 percent on Tuesday.
  • Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) shares fell 13.5 percent to $7.22 in pre-market trading after climbing 46.49 percent on Tuesday.
  • EnteroMedics Inc (NASDAQ: ETRM) shares fell 10.8 percent to $24.70 in pre-market trading after rising 56.50 percent on Tuesday.
  • GenVec Inc (NASDAQ: GNVC) fell 9 percent to $8.00 in pre-market trading after jumping 76.86 percent on Tuesday.
  • Bluerock Residential Growth REIT Inc (NYSE: BRG) fell 5.7 percent to $13.05 in pre-market trading after the company announced a 4 million share offering.
  • Archer Daniels Midland Company (NYSE: ADM) fell 5.6 percent to $41.96 in pre-market trading as the company agreed to acquire Crosswind Industries, Inc.
  • Performance Food Group Co (NYSE: PFGC) shares fell 5.2 percent to $22.80 in pre-market trading. Performance Food Group priced its 10 million share offering at $22.85 per share.
  • Signet Jewelers Ltd. (NYSE: SIG) shares fell 4.5 percent to $83.53 in pre-market trading as the company lowered its profit and sales forecast for the full year.
  • Parsley Energy Inc (NYSE: PE) shares fell 3.2 percent to $35.50 in pre-market trading. Parsley Energy reported that it has priced its upsized 22 million share offering of Class A common stock for gross proceeds of $770 million.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMovers#PreMarket GainersLosersTop Gainers